Tokyo Tape
Sign in
← Santen Pharmaceutical

Quarterly report · Q2

4536.TEDINET S100S66I
Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥145.8bn2023-04-01 → 2023-09-30Cons.Revenue IFRS
Revenue¥73.4bn2023-07-01 → 2023-09-30dCons.Revenue IFRS
Revenue¥279.0bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥128.9bn2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥63.4bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Operating income¥25.1bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Operating income¥12.3bn2023-07-01 → 2023-09-30dCons.Operating profit loss IFRS
Operating income−¥19.0bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income−¥27.4bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Profit before tax¥24.1bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Profit before tax¥11.2bn2023-07-01 → 2023-09-30dCons.Profit loss before tax IFRS
Profit before tax−¥5.8bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥19.1bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥28.2bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥19.3bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥8.9bn2023-07-01 → 2023-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥14.9bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥22.0bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥28.7bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥19.3bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Net income¥8.9bn2023-07-01 → 2023-09-30dCons.Profit loss IFRS
Net income−¥22.0bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income−¥28.7bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Total assets¥427.0bnat 2023-09-30Cons.Assets IFRS
Total assets¥421.2bnat 2023-03-31Cons.Assets IFRS
Total assets¥426.6bnat 2022-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥120.5bnat 2023-09-30Cons.Liabilities IFRS
Total liabilities¥127.9bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥306.5bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥293.3bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥309.4bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥336.8bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥307.2bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥294.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥310.1bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥64.7bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥57.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥69.1bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥83.0bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥27.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥37.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥18.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥26.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥18.8bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥19.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥37.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥16.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥52.062023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥24.62023-07-01 → 2023-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥-38.62022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-56.052022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-75.562022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥51.922023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥24.522023-07-01 → 2023-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-38.62022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-56.052022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-75.562022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio71.9%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio69.8%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio72.7%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 674
ItemContextValueUnit
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant－
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of group (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus
Management analysis of financial position operating results and cash flows (text)FilingDateInstantText · Plus
Critical contracts for operation (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所プライム市場
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)完全議決権株式であり、権利内容に何ら限定のない当社における標準となる株式。単元株式数は100株です。
Details of employee share option program (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)日本マスタートラスト信託銀行株式会社（信託口）
Address major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)東京都港区浜松町２丁目11－３
Name major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)株式会社日本カストディ銀行（信託口）
Address major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)東京都中央区晴海１丁目８－12
Name major shareholdersCurrentQuarterInstant_No3MajorShareholdersMemberText · Plus
Address major shareholdersCurrentQuarterInstant_No3MajorShareholdersMemberText · Plus
Name major shareholdersCurrentQuarterInstant_No4MajorShareholdersMember
Original text (Japanese)BNYM AS AGT/CLTS NON TREATY JASDEC(常任代理人　株式会社三菱UFJ銀行)
Address major shareholdersCurrentQuarterInstant_No4MajorShareholdersMemberText · Plus
Name major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)日本生命保険相互会社（常任代理人 日本マスタートラスト信託銀行株式会社）
Address major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)東京都千代田区丸の内１丁目６－６（東京都港区浜松町２丁目11－３）
Name major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)株式会社三菱UFJ銀行
Address major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)東京都千代田区丸の内２丁目７－１
Name major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)GOVERNMENT OF NORWAY（常任代理人 シティバンク、エヌ・エイ東京支店）
Address major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)BANKPLASSEN 2, 0107 OSLO 1 OSLO 0107 NO（東京都新宿区新宿６丁目27－30）
Name major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)BNYM AS AGT/CLTS 10 PERCENT(常任代理人　株式会社三菱UFJ銀行)
Address major shareholdersCurrentQuarterInstant_No8MajorShareholdersMemberText · Plus
Name major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)みずほ信託銀行株式会社　退職給付信託　エーザイ口　再信託受託者　株式会社日本カストディ銀行
Address major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)東京都中央区晴海１丁目８－12
Name major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)小野薬品工業株式会社
Address major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)大阪市中央区道修町２丁目１－５
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember
Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式。単元株式数は100株です。
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsOtherMember
Original text (Japanese)同上
Description issued shares voting rightsCurrentQuarterInstant_SharesLessThanOneUnitMember
Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式。
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)参天製薬株式会社
Address of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)大阪市北区大深町４番20号
Information about officers (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2023-07-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass